Cost Effectiveness of Insulin Degludec Plus Liraglutide (IDegLira) in a Fixed Combination for Uncontrolled Type 2 Diabetes Mellitus in Sweden.

Åsa Ericsson,Adam Lundqvist

Cost Effectiveness of Insulin Degludec Plus Liraglutide (IDegLira) in a Fixed Combination for Uncontrolled Type 2 Diabetes Mellitus in Sweden.

2017

Åsa Ericsson
Adam Lundqvist

Background Patients with uncontrolled type 2 diabetes mellitus (T2DM) are a priority group for intensified therapy without weight gain and with low risk of hypoglycaemia.

Keywords:

Physical therapy
Weight gain
Liraglutide
Insulin detemir
Insulin glargine
Insulin degludec
Type 2 Diabetes Mellitus
Internal medicine
Endocrinology
Insulin aspart
Medicine
Diabetes mellitus
Pediatrics
cost effectiveness

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations